Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
- Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States, Australia, France, Italy, South Korea +3 more
- A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis PigmentosaCompleted
Sponsor: Novartis Pharmaceuticals
Retinitis Pigmentosa
Sweden
Sponsor: Novartis Pharmaceuticals
Secondary Malignancies of T-cell Origin
Japan
Sponsor: Novartis Pharmaceuticals
Hematologic Malignancy · Solid Tumor · Advanced Malignancies
United States, Belgium, Italy, Netherlands, United Kingdom
Sponsor: Novartis Pharmaceuticals
Advanced Solid Tumors Which Are cMET-dependent
United States, Belgium, Canada, China, Denmark +6 more
- Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA MutationActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Advanced HER2+Breast Cancer
United States, Belgium, China, France, Italy +2 more
- Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
ALK-positive NSCLC
United States, Australia, Belgium, Canada, Hong Kong +3 more
- Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia VeraActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Polycythemia Vera
Italy
- Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored StudyActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
ALK Positive Malignancies
United States, Australia, Belgium, Brazil, Bulgaria +16 more
- Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Breast Neoplasms
China
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis (RMS)
Greece
- Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking OfatumumabEnrolling By Invitation
Sponsor: Johns Hopkins University
Multiple Sclerosis · Tomography, Optical Coherence · Retinal Degeneration · Visual Acuity
United States
- Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLTActive Not Recruiting
Sponsor: East Coast Institute for Research
Primary Open Angle Glaucoma or Ocular Hypertension
United States
- A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease PatientsRecruiting
Sponsor: Novartis Pharmaceuticals
Familial Mediterranean Fever · Still Disease · Systemic Juvenile Idiopathic Arthritis · Adult-Onset Still Disease
Switzerland
Sponsor: Novartis Pharmaceuticals
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
India
Sponsor: Novartis Pharmaceuticals
Sickle Cell Disease
United States, Belgium, Brazil, Colombia, France +6 more
- A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
United States, Australia, Austria, Belgium, Bulgaria +24 more
Sponsor: M.D. Anderson Cancer Center
Philadelphia Chromosome-Positive · Acute Lymphoblastic Leukemia
United States
Sponsor: Novartis Pharmaceuticals
Prostatic Neoplasms
United States, Austria, Belgium, Canada, China +14 more
Sponsor: Novartis Pharmaceuticals
Graft-Versus-Host Disease
Japan
- Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid LeukemiaRecruiting
Sponsor: M.D. Anderson Cancer Center
Malignant Solid Tumors
United States
Sponsor: Cellerys AG
Relapsing-remitting Multiple Sclerosis (RRMS)
Czechia, Germany, Italy, Switzerland
Sponsor: Novartis Pharmaceuticals
Graft vs. Host Disease · Chronic Graft vs. Host Disease · Corticosteroid-refractory Chronic Graft vs. Host Disease
China
Sponsor: Novartis Pharmaceuticals
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
China
Sponsor: Novartis Pharmaceuticals
Sjögrens Disease · Systemic Lupus Erythematosus · Rheumatoid Arthritis
United States, Argentina, Canada, Czechia, Hungary +3 more